Literature DB >> 9199368

Essential role of heparan sulfates in axon navigation and targeting in the developing visual system.

A Walz1, S McFarlane, Y G Brickman, V Nurcombe, P F Bartlett, C E Holt.   

Abstract

Heparan sulfate (HS) is abundant in the developing brain and is a required co-factor for many types of fibroblast growth factor (FGF) signaling in vitro. We report that some HSs, when added exogenously to the developing Xenopus optic pathway, severely disrupt target recognition causing axons from the retina to bypass their primary target, the optic tectum. Significantly, HS sidechains from a neuroepithelial perlecan variant that preferentially bind FGF-2, HS(FGF-2), cause aberrant targeting, whereas those that preferentially bind FGF-1 do not. Charge-matched fragments of HS(FGF-2) show that the mistargeting activity associates with the FGF-binding fragments. Heparitinase removal of native HSs at the beginning of optic tract formation retards retinal axon elongation; addition of FGF-2 restores axon extension but axons lose directionality. Late HS removal, after axons have extended through the tract, elicits a tectal bypass phenotype indicating a growth promoting and guidance function for native HSs. Our results demonstrate that different HS sidechains from the same core protein differentially affect axon growth in vivo, possibly due to their distinct FGF-binding preferences, and suggest that growth factors and HSs are important partners in regulating axon growth and guidance in the developing visual system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199368     DOI: 10.1242/dev.124.12.2421

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  36 in total

1.  Roles of the telencephalic cells and their chondroitin sulfate proteoglycans in delimiting an anterior border of the retinal pathway.

Authors:  H Ichijo; I Kawabata
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.

Authors:  A Radu Aricescu; Iain W McKinnell; Willi Halfter; Andrew W Stoker
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 3.  Proteoglycans as cues for axonal guidance in formation of retinotectal or retinocollicular projections.

Authors:  Hiroyuki Ichijo
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

4.  Characterization of a chondroitin sultate proteoglycan associated with regeneration in goldfish optic tract.

Authors:  Michael A Pizzi; John S Elam
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

5.  Targeting of retinal axons requires the metalloproteinase ADAM10.

Authors:  Yuanyuan Y Chen; Carrie L Hehr; Karen Atkinson-Leadbeater; Jennifer C Hocking; Sarah McFarlane
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 6.  Molecular mechanisms of optic axon guidance.

Authors:  Masaru Inatani
Journal:  Naturwissenschaften       Date:  2005-10-12

7.  Dynamic responses of Xenopus retinal ganglion cell axon growth cones to netrin-1 as they innervate their in vivo target.

Authors:  Nicole J Shirkey; Colleen Manitt; Liliana Zuniga; Susana Cohen-Cory
Journal:  Dev Neurobiol       Date:  2012-04       Impact factor: 3.964

8.  The winged helix transcription factor Foxg1 facilitates retinal ganglion cell axon crossing of the ventral midline in the mouse.

Authors:  Thomas Pratt; Natasha M M-L Tian; T Ian Simpson; John O Mason; David J Price
Journal:  Development       Date:  2004-07-07       Impact factor: 6.868

9.  E3 ligase Nedd4 promotes axon branching by downregulating PTEN.

Authors:  Jovana Drinjakovic; Hosung Jung; Douglas S Campbell; Laure Strochlic; Asha Dwivedy; Christine E Holt
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

10.  A role for S1P signalling in axon guidance in the Xenopus visual system.

Authors:  Laure Strochlic; Asha Dwivedy; Francisca P G van Horck; Julien Falk; Christine E Holt
Journal:  Development       Date:  2007-12-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.